Navigation Links
Savient Reaches Agreement To Sell Substantially All Assets To Crealta Pharmaceuticals
Date:12/11/2013

BRIDGEWATER, N.J. and GLENDALE, Wis., Dec. 11, 2013 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) ("Savient") announced today that it has reached agreement on the terms of an acquisition agreement with Crealta Pharmaceuticals LLC ("Crealta") through which Crealta would acquire substantially all of the assets of Savient, including all KRYSTEXXA® assets, for gross proceeds of approximately $120.4 million.  The agreement was reached following an auction conducted pursuant to bidding procedures approved by the U.S. Bankruptcy Court for the District of Delaware (the "Court").  A hearing at which Savient and Crealta will seek the required Court approval of the sale is scheduled for Friday, December 13, 2013.

According to the terms of the acquisition agreement, Crealta will purchase Savient's pharmaceutical portfolio, which is highlighted by the chronic refractory gout drug KRYSTEXXA®.  KRYSTEXXA® is a novel biologic product that was designated as an orphan drug by the FDA based on the relatively small patient population with refractory chronic gout ("RCG").  KRYSTEXXA® is a PEGylated uric acid specific enzyme, or uricase, that has been shown to dramatically reduce uric acid levels for many patients suffering from RCG.

"We are thrilled to be able to acquire KRYSTEXXA from Savient, thus ensuring the continued availability of an important therapy for patients suffering from what can be a debilitating condition," said Ed Fiorentino, Chairman and CEO of Crealta.  "Crealta is committed to providing education and support to patients and their health care providers so that KRYSTEXXA can continue to be used safely and effectively.  KRYSTEXXA represents the type of product that Crealta strives to deliver to patients, namely specialty products addressing significant health care conditions. &
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.; Crealta Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Savient Reaches Agreement On Use Of Cash Collateral
2. Savient Pharmaceuticals Reports Second Quarter 2013 Financial Results
3. Savient Pharmaceuticals Reports First Quarter 2013 Financial Results
4. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Tuesday, March 19, 2013
5. Savient Announces the Election of Robert G. Savage to its Board of Directors
6. Savient Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. Savient Pharmaceuticals to Present at the 6th Annual Imperial Capital Global Opportunities Conference
8. Savient Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
9. Savient Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
10. Savient Pharmaceuticals Adopts Stockholder Rights Plan
11. Savient Pharmaceuticals Receives Favorable Decision In Tang Capital Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... CHESTERBROOK, Pa. and STOCKHOLM ... AB (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc. today ... Use (CHMP) of the European Medicines Agency (EMA) has ... (collagenase clostridium histolyticum) for the treatment of adult men ... deformity of at least 30 degrees at the start ...
(Date:12/22/2014)... Maine , Dec. 22, 2014  Mark ... analysis brief providing a summary of the 2015 ... plan enrollment trends.  According to ... for Planning and Evaluation, Department of Health and ... were enrolled in individual medical plans through the ...
(Date:12/22/2014)... , Dec. 22, 2014  Pfenex Inc. (NYSE ... recombinant anthrax vaccine, has been filed and is now ... provided by the Department of Health and Human Services ... (BARDA). "We are extremely pleased to have ... Px563L.  This represents a significant milestone in our company,s ...
Breaking Medicine Technology:Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Insights into the Marketplace and Individual Market Growth 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 3
... Ikaria Holdings, Inc. today announced that it has been ... by the New Jersey Business & Industry Association (NJBIA), ... Ikaria earned the award based on criteria including ... creation of new jobs. , "We are delighted that ...
... 21 PharmaNet Development Group, Inc., a leading provider ... and medical device companies, today announced its participation at ... place at the World Trade Center in Rotterdam, The ... the conference, top management will discuss some of the ...
Cached Medicine Technology:Ikaria Receives Award for Excellence by New Jersey Business & Industry Association 2PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam 2
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... Ducks Publishing announces the winning of the Mom,s Choice Award for ... The award-winning book, a remarkably frank account of prostate cancer survival, ... , ... South Bend, IN (PRWEB) March 19, 2009 ...
... March 19 The "2009 European Mammography ... to FUJIFILM Corporation in recognition of the ... mammography systems. The company,s superior quality control, ... manufacturing are also commended.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
... designed to extend audit reach for customers that need ... SAFC(R), a member of the Sigma-Aldrich Group (Nasdaq: ... new Vendor Audit Services aimed at customers ... raw materials and key intermediates destined for their manufacturing ...
... For women with recurrent breast cancer, the treatment the ... original breast cancer. A group from Toronto has recently completed ... with a biopsy of suspected tumors that recurred elsewhere in ... 20% of the women having a significant change in their ...
... Injury Awareness MonthWHEATON, Ill., March 18 Sports and recreation ... in the U.S. each year according to the Centers for ... traumatic brain injury (TBI) caused by a blow or jolt ... It is important to note that even if you do ...
... Keystone Symposia on Molecular and Cellular Biology will ... in 1984 when it convenes its scientific conferences on ... From Infection to Immune Control " at Keystone Resort ... from around the world will attend.These joint conferences will ...
Cached Medicine News:Health News:Cancer Book Honored With Prestigious Mom's Choice Award 2Health News:Frost & Sullivan Recognises FUJIFILM Corporation's Outstanding Product Quality Leadership 2Health News:Frost & Sullivan Recognises FUJIFILM Corporation's Outstanding Product Quality Leadership 3Health News:Frost & Sullivan Recognises FUJIFILM Corporation's Outstanding Product Quality Leadership 4Health News:SAFC(R) Underlines Commitment to Pharmaceutical Supply Chain Quality With New Global Vendor Audit Services 2Health News:SAFC(R) Underlines Commitment to Pharmaceutical Supply Chain Quality With New Global Vendor Audit Services 3Health News:SAFC(R) Underlines Commitment to Pharmaceutical Supply Chain Quality With New Global Vendor Audit Services 4Health News:Research shows biopsy of recurrent breast cancer can alter treatment 2Health News:Sports Concussions: Common and Preventable 2Health News:Keystone Symposia to Mark 25th Anniversary of its First HIV/AIDS Meeting 2Health News:Keystone Symposia to Mark 25th Anniversary of its First HIV/AIDS Meeting 3
... has the right product for any patient ... intubated patients to patients with tracheotomies. These ... and critical care applications., ,The Unti-Mist ... patients and staff members. This entire product ...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Ballard trach care HMES and filters, universal use, "Y" filter, CO 2 sampling port...
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
Medicine Products: